Professor Mark Richards, Director of the Cardiovascular Research Institute, National University Heart Centre Singapore, heads the Cardiovascular Disease Summit Research Programme (SRP). The team consists of a strong base of researchers in clinical cardiology, biochemistry, microbiology and protein chemistry.
This SRP focuses on heart failure and coronary heart disease, both leading causes of death in Singapore and around the world. Researchers in the programme are using protein, microRNA and epigenetic markers, as well as developing new markers, to discover novel diagnostics and treatments for these conditions. They can take advantage of their large patient cohorts and strong collaborations to conduct clinical testing of candidate diagnostics and treatments.